PS.

Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)

NHS EnglandcontractContracts Finder ↗Ref CF-3150800D0O000000rwimUAAcomplete

Estimated value

£1.7m

Awarded value

£1.7m

Awarded 30 Mar 2025

Suppliers

1

Lots

1

1 awarded

Published

27 Aug 2025

Deadline 31 Mar 2025

Description

Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England

Scope

Reference
CF-3150800D0O000000rwimUAA
Total value
£1,677,290 excluding VAT
Commercial tool
Standalone contract
Contract dates
31 Mar 2025 to 30 Mar 2027
CPV classifications
33696200

Submission & procedure

Submission deadline
31 Mar 2025, 11:00 am

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£1.7m

Award date

30 Mar 2025

Contract start

31 Mar 2025

Contract end

30 Mar 2027

Awarded to
RL
Revvity (UK) Limited